Cell Therapy

Type: Keyphrase

Name: Cell Therapy

First reported 12 hours ago - Updated 12 hours ago - 1 reports

Roadmap for Commercialising Stem-Cell Based Therapies

Day One – Morning Session – World Stem Cells and Regenerative Medicine Congress Europe 2013Professor Chris Mason , of the Regenerative Medicine Bioprocessing Unit at the Advanced Centre for Biochemical Engineering , University College London, chaired ... [Published Terrapinn - 12 hours ago]

Entities: Regenerative Medicine, Keith Thompson, Stem Cell, Cell Therapy, John Krebs

First reported May 23 2013 - Updated May 23 2013 - 1 reports

Phase II

Guest blog: Cell therapy approval and reimbursement must pace in synch within the modern scenarios

Cell therapy approval and reimbursement must pace in synch within the modern scenarios.Gil Van Bokkelen, Athersys CEO, and Micheal Werner, Alliance for Regenerative Medicine Co-founder and Executive Director, explained the requirements for the delicate ... [Published Terrapinn - May 23 2013]

Entities: Cell Therapy, Regenerative Medicine, Phase II, Athersys Inc

First reported May 22 2013 - Updated May 23 2013 - 1 reports

Progress after recent breakthrough which opened new chapter in anti-cancer cell therapies

(Hackensack, NJ) John Theurer Cancer Center at Hackensack University Medical Center, one of the nation's top 50 cancer centers, will bring together leading cancer experts, for presentation and discussion of the latest developments and implications of ... [Published Bio-Medicine - May 22 2013]

Entities: T-cells, Cancer, Immunology

First reported May 22 2013 - Updated May 22 2013 - 2 reports

Regenerative Medicine Markets

NEW YORK Regenerative medicine is a way of treating injured and diseased human tissue by using laboratory-grown or therapeutically-induced human tissue as a replacement. As such, astounding new advancements in the ability to repair or replace damaged ... [Published TheStreet.com - May 22 2013]

Entities: Cell Therapy, Stem Cell, Regenerative Medicine, Tissue Engineering

First reported May 22 2013 - Updated May 22 2013 - 1 reports

Ask the vet: Ease joint pain in cats and dogs$

Answer: Osteoarthritis is a progressive and painful degenerative joint disease resulting from the breakdown of joint cartilage, leading to friction inside the joint.It is one of the most common diseases of old age in dogs and cats.Many factors such as ... [Published Camden Advertiser - May 22 2013]

Entities: Cartilage, Osteoarthritis, Inflammation, Geriatrics

First reported May 22 2013 - Updated May 22 2013 - 1 reports

Can Ignoring Shoulder Pain Lead to Arthritis

- CLEARWATER, Fla. -- Shoulders problems are a frequent problem in athletes and non-athletes alike.Trauma is a known predisposing factor for the development of arthritis, and now genetic factors have also been implicated in the development of arthritis. ... [Published Prlog - May 22 2013]

Entities: Arthritis, Regenerative Medicine, Cell Therapy

First reported May 22 2013 - Updated May 22 2013 - 1 reports

Guest blog: Assessing the uptake and impact of the Cell Therapy Catapult Centre

Home » Blogs » Related Biotechnology, Pharmaceutical and Healthcare NewsCCRM and Cell Therapy Catapult Sponsored Drinks Reception VIEW SLIDE SHOW DOWNLOAD ALL Cell Therapy Catapult: a global leader in bridging the translational gap of [...]Original Article: ... [Published BioPortfolio - May 22 2013]

Entities: Cell Therapy, Biotechnology, Health Care, BioPortfolio Ltd

First reported May 21 2013 - Updated May 22 2013 - 3 reports

Guest blog: Assessing the uptake and impact of the Cell Therapy Catapult Centre

CCRM and Cell Therapy Catapult Sponsored Drinks Reception VIEW SLIDE SHOW DOWNLOAD ALLCell Therapy Catapult : a global leader in bridging the translational gap of new cell therapies.Yesterday morning at the World Stem Cells & Regenerative Medicine ... [Published Terrapinn - May 22 2013]

Entities: Cell Therapy, Keith Thompson, Regenerative Medicine, Stem Cell, collaboration

First reported May 22 2013 - Updated May 22 2013 - 1 reports

Sca-1+ Cardiac Progenitor Cell Therapy With Cells Overexpressing Integrin-Linked Kinase Improves Cardiac Function After Myocardial Infarction

Background: This study was to investigate the effect of integrin-linked kinase (ILK) on the transplantation efficiency of stem cell antigen-1–positive cardiac progenitor cells (Sca-1+ CPCs) in a mouse myocardial infarction (MI) model.Methods: Sca-1+ CPCs ... [Published Transplantation - May 22 2013]

Entities: Myocardial Infarction, Kinase, Cell Therapy

First reported May 20 2013 - Updated May 21 2013 - 2 reports

BioRestorative Therapies Signs Agreement with Dexterity, Inc. to Advance Production of the Company's Novel brtxDISC? Stem Cell Therapy Device

/PRNewswire/ -- BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTC BB: BRTX), a life sciences company focused on developing stem cell based therapies for various personal applications, announces the signing of a consulting agreement with Dexterity, ... [Published Miami Herald - May 20 2013]

Entities: Stem Cell, Cell Therapy, Clinical trials, Cell Culture, Product Design

First reported May 20 2013 - Updated May 20 2013 - 1 reports

Sports Medicine New Frontiers: Platelet-Rich-Plasma (PRP) and Stem Cell Therapy

Sports Medicine is always at the forefront of innovative medical technology. Athletes are constantly striving to improve. Records are broken as humans run faster, jump higher, and strive for higher levels of performance. Athletes expose their bodies to ... [Published Zecco - May 20 2013]

Entities: Stem Cell, Cell Therapy, Sports Medicine, Regenerative Medicine

First reported May 20 2013 - Updated May 20 2013 - 1 reports

Cell Therapy Catapult appoints CSO

Professor Johan Hyllner The , which is focused on the development of the UK cell therapy industry, has appointed Professor Johan Hyllner to its executive management team as Chief Scientific Officer (CSO). He joins from French company Cellectis, where ... [Published Manufacturing Chemist - May 20 2013]

Entities: Cell Therapy, Cellectis SA, Appointed

Quotes

"This proves regenerative medicine can take place in any hospital," Yerden continued. "Aspiring cell therapists are no longer dependent on the limited number of multi-million dollar clean rooms, usually only found in large tertiary hospitals and research centers. Now other brilliant surgeons like Dr. Holterman and his team can begin engaging in organ engineering wherever they practice."

Lifesaving Medical Treatment Possible for Child Born Without a Trachea [Published HealthNewsDigest.com - 6 hours ago]

...The title of Dr Bartus' talk was: "CERE-120 (AAV2- neurturin) for the treatment of Parkinson's disease: Experience from 4 clinical trials and human autopsy data"

Ceregene announces additional efficacy data from phase IIb study of CERE-120 to treat Parkinson's ... [Published PharmaBiz - 13 hours ago]

...from Sangamo's PhasePhase 1 clinical trial SB-728-902 Cohorts 1-3 in a second presentation at 2:15 pm MT, on Thursday, May 16, 2013, Abst.#: 58 "Long Term CD4 Reconstitution in HIV Subjects Receiving ZFN CCR5 Modified CD4 T-Cells (SB-728-T) May Be Attributed to the Sustained Durability of the Central Memory T-Cell Subset."

Sangamo BioSciences Presents Clinical Data Demonstrating HIV Reservoir Reduction in HIV-Infected ... [Published National AIDS Treatment Advocacy Project - May 23 2013]

...to our growing pipeline of drug-eluting stent technologies," said Kevin Ballinger, president, Interventional Cardiology, Boston Scientific. "These innovations reflect our commitment to interventional cardiologists and the patients they serve."

Boston Scientific Announces Results from Promus Premier; Salix's Budesonide Foam Shows Significan ... [Published BioMedReports - May 23 2013]

More Content

sort by: Date \| Relevance
Lifesaving Medical Treatment Possible for Chil... [Published HealthNewsDigest.com - 6 hours ago]
Roadmap for Commercialising Stem-Cell Based The... [Published Terrapinn - 12 hours ago]
Ceregene announces additional efficacy data fro... [Published PharmaBiz - 13 hours ago]
Neuralstem Principal Investigator, Dr. Eva Feld... [Published NewsRX - May 24 2013]
Mesenchymal Stem Cells as Vectors for Lung Canc... [Published Sexual Development - May 23 2013]
Guest blog: Cell therapy approval and reimburse... [Published Terrapinn - May 23 2013]
Sangamo BioSciences Presents Clinical Data Demo... [Published National AIDS Treatment Advocacy Project - May 23 2013]
Boston Scientific Announces Results from Promus... [Published BioMedReports - May 23 2013]
Green as Grass [Published Proactive Investors USA - May 22 2013]
Regenerative Medicine Markets [Published TheStreet.com - May 22 2013]
Regenerative Medicine Markets [Published Zecco - May 22 2013]
Progress after recent breakthrough which opened... [Published EurekAlert! - May 22 2013]
Progress after recent breakthrough which opened... [Published Bio-Medicine - May 22 2013]
Can Ignoring Shoulder Pain Lead to Arthritis [Published Prlog - May 22 2013]
Guest blog: Assessing the uptake and impact of ... [Published BioPortfolio - May 22 2013]
Guest blog: Assessing the uptake and impact of ... [Published Terrapinn - May 22 2013]
Guest blog: The Biotech Bull and its impact of ... [Published Terrapinn - May 22 2013]
Sca-1+ Cardiac Progenitor Cell Therapy With Cel... [Published Transplantation - May 22 2013]
Ask the vet: Ease joint pain in cats and dogs$ [Published Camden Advertiser - May 22 2013]
Goodie Mob Is Back [Published AOL Black Voices - May 21 2013]
Research at the cutting edge of knowledge [Published EurekAlert! - May 21 2013]
Fearful for direction as sector struggles, slip... [Published Proactive Investors USA - May 21 2013]
Cell Therapy Catapult releases preclinical data... [Published Pharma Times - May 21 2013]
Cell Therapy Catapult to work with GSK [Published Manufacturing Chemist - May 21 2013]
Medistem, Inc. Appoints Herm Rosenman to Board ... [Published FinanzNachrichten.de - May 21 2013]
Stocks in Focus (OSI Systems, Empresas ICA SA, ... [Published SBWire - May 21 2013]
Ceregene Reports Additional Efficacy Data From ... [Published Digital Journal - May 21 2013]
Ceregene Reports Additional Efficacy Data From ... [Published Michigan Live - May 21 2013]
Latest European Discovery in Chronic Back Pain ... [Published PRWeb - May 21 2013]
Neuralstem ALS Trial Principal Investigator, Dr... [Published Barchart - May 20 2013]

sort by: Date \| Relevance
U.S. Catholic critics slam new cloning research [Published FaithWorld - May 16 2013] (A researcher works in his laboratory at the Institute for Stem cell Therapy and Exploration of Monogenic Diseases (I-Stem) in Evry, near Paris November 27, 2009. REUTERS/Gareth Watkins ) U.S. scientists’ assertion that the advance in therapeutic ...
Cell Therapy Promise Highlighted at UCSF Symposium [Published UCSF News - May 08 2013] UCSF recently convened experts to discuss cell therapies, which have already saved children and adults from leukemia in clinical trials after other drugs failed them. ...
MGE: Brain Cells Transplant Cures Epilepsy In Mice [Published Scientific Blogging - Neuroscience - May 06 2013] Researchers were able to controll seizures in epileptic mice with a one-time transplantation of medial ganglionic eminence (MGE) cells into the hippocampus, which inhibit signaling in overactive nerve circuits. Cell therapy has become a focus of epilepsy ...
Leading Researchers Emphasize Need to Regulate ... [Published About.com Biotech / Biomedical - May 04 2013] Thirteen of the world's leading stem cell researchers just published a statement in the European Molecular Biology Organization (EMBO) Journal expressing alarm about initiatives to deregulate stem cell therapies. Recent actions by the Italian government ...
Stem Cell Therapy: Leading Edge Medicine Or 21s... [Published Scientific Blogging - Apr 17 2013] In 2013, stem cell therapy is touted as the future ofmedicine by proponents in Europe and Asia while scientists in America urgecaution. Contrast that to a decade ago, when the concern was that AmericanPresident George W. Bush was holding back progress ...